Creating sustainable long-term value for our company, employees, shareholders and other stakeholders.
As a leading funder of innovation, we recognize the importance of integrating Environmental, Social and Governance (ESG) principles into our strategies and investments.
We play an important role in accelerating innovation in life sciences and transforming patient lives
Through our policies and practices, designed to minimize our ESG risk, we uphold our commitments to our partners and other stakeholders.
Founder and Chief Executive Officer
Royalty Pharma is committed to expanding our sustainable development strategy
Aligning to the United Nations (UN) Sustainable Development Goals (SDGs)
Our efforts are closely aligned to four of the United Nations Sustainable Development Goals (UNSDGs), where we believe we can have the greatest impact, based on our business, strategy and expertise.
Our comprehensive approach to responsible investment has been sharpened over 25+ years. We promote responsible practices through our investment process, partner selection and due diligence.
Engaging with our stakeholders
As part of our materiality assessment, we conducted a range of stakeholder surveys, interviews and workshops, alongside wider analysis and industry research, to help identify the key areas of focus for our business to prioritize ESG issues.
Supporting our communities
We aim to give back to the communities where we live and work, as well as help to provide the funds and resources required to address the healthcare challenges of a complex and evolving world.Find out more